可能性最大的诊断是急性心肌梗死。
背景：经皮冠状动脉介入(PCI)治疗是急性心肌梗死的有效治疗方法。
Background: Percutaneas Coronary interventional (PCI) therapy is a effective treatment to acute myocardial infarction.
心源性休克是急性心肌梗死的严重并发症，是引起急性心肌梗死患者死亡的主要原因。
Cardiogenic shock is the serious complication of acute myocardial infarction., it is the leading cause of death for patients with acute myocardial infarction.
目的：心脏破裂是急性心肌梗死(ami)最严重而并不少见的并发症，是心肌梗死主要死亡原因之一。
Objective: Cardiac rupture is the most dramatic and severe complication of acute myocardial infarction (AMI), which is mainly responsible for in-hospital death.
“静脉内注射ANP是急性心肌梗死(ami)一项有前景的辅助治疗，”作者在《美国心脏病学会杂志》上写道。
"Intravenous administration of ANP is a promising candidate for an adjunctive therapy for AMI," the authors write in the Journal of the American College of Cardiology.
冠脉支架置入术已经成为治疗冠心病尤其是急性心肌梗死的主要手段之一，并为降低急性心肌梗死死亡率作出了巨大贡献。
Coronary stenting has been one of the leading methods for treating coronary heart diseases, especially of acute myocardial infarction, and for reducing its mortality.
结果临床误诊的主要原因是：对不典型急性心肌梗死的心电图认识不足以及讯问病史、全面体检不详细。
Results inadequate recognition of electrocardiography, as well as inadequate interrogation of the medical history and incorrect physical examination, was the cause of misdiagnosis.
目的：急性心肌梗死(ami)是严重危害人类健康和生命的疾病之一。
Objective: Acute myocardial infarction (AMI) is a serious disease which dose harm to the health of human being.
背景：快速、准确地诊断急性心肌梗死是极需满足的临床需要。
Background: The rapid and reliable diagnosis of acute myocardial infarction is a major unmet clinical need.
冠心病急性心肌梗死(ami)是世界范围内严重威胁人类生命的疾病，早期诊断急性心肌梗死对挽救病人生命非常重要。
Acute myocardial infarction (AMI) is a deadly disease to threat human life world wide, and it is crucial to save the threaten lives with early detection of AMI.
急性心肌梗死是临床常见的危急重症，其发病率日渐增高。
Acute myocardial infarction is a frequently occurring and dangerous disease, whose morbidity is increasing gradually.
急性心肌梗死是全球范围内致死和致残的主要疾病之一。
Acute myocardial infarction is one of the major diseases which lead to death and disability worldwide.
血清心肌损伤标志物水平的升高是诊断急性心肌梗死的重要依据。
Serum cardiac markers elevation is an important basis for diagnosis of acute myocardial infarction.
结论：急性心肌梗死患者血清mcp 1水平明显增高，是显示斑块不稳定性的重要标志之一。
Conclusions: Serum MCP-1 level is elevated in acute myocardial infarction, indicating its role as a marker predicting the rupture of unstable plaques.
不稳定型心绞痛是冠心病中常见的类型，是介于稳定型心绞痛与急性心肌梗死和猝死之间的临床状况。
Unstable angina pectoris(UAP) is a common coronary heart disease with a clinical symptom situated between stable angina pectoris and acute myocardial infarction.
结论左心房功能是预测急性心肌梗死患者近期预后的较好的指标。
Conclusion the index of the left atrial function is a better index which is used to predict the short-term prognosis in patients with acute myocardial infarction.
急性心肌梗死患者QT变异度指数增高，可能是由于急性心肌梗死造成的心肌缺血和坏死使心室复极变异增大。
But QTVI of AMI was higher than the control group, which suggested greater repolarization liability in AMI caused by myocardial ischemia and infarction.
结论对急性心肌梗死患者实施不同再灌注治疗是安全有效的，应重视对合并心源性休克患者开展直接冠状动脉成形术和急症冠状动脉搭桥术。
Conclusions Reperfusion therapy is a safe and effective therapeutic maneuver for patient with AMI, moreover, primary PCI or emergency CABG may be more preferable in cardiac shock patients.
结论冠脉内支架植入术及联合抗凝治疗急性心肌梗死是有效、安全的，可减少并发症的发生。
Conclusions Primary stent implantation with associated anticoagulation therapy is effective and safe, it can reduce complications incidence.
结论急性心肌梗死行ptca及支架治疗是安全有效的。
Conclusion It is safe and effective in treating acute myocardial infarction by PTCA and stent implantation.
急性心肌梗死是冠心病中的危重症，病死率高。
Acute myocardial infarction is a very serious disease with a high mortality.
结论替罗非班在急性心肌梗死的急诊介入治疗过程中是有效的和安全的。
Conclusion Tirofiban to emergency intervention therapy in paitent with acute myocardial infarction is effective and safe.
结论：ST段抬高急性心肌梗死患者在急诊pci术前应用盐酸替罗非班是安全有效的。
Conclusion: ST-segment elevation acute myocardial infarction patients before surgery in the emergency PCI tirofiban hydrochloride is safe and effective.
结论：年龄、性别、冠脉病变程度等是影响急性ST段抬高型心肌梗死患者生活质量的因素。
Conclusion: Age, gender and severity of coronary artery disease are factors influence on quality of life in patients with acute ST segment elevation myocardial infarction.
防止左室重构进展是治疗急性心肌梗死(MI)的关键点。
Preventing progressive left ventricular remodeling is a key therapeutic objective after acute myocardial infarction (MI).
本实验结果表明：人EG细胞异种异体移植治疗急性心肌梗死是可行的。
This experiment indicates that it is feasible to xenogeneically transplant hEGCs into infracted myocardium.
本实验结果表明：人EG细胞异种异体移植治疗急性心肌梗死是可行的。
This experiment indicates that it is feasible to xenogeneically transplant hEGCs into infracted myocardium.
应用推荐